Clinical Trial Update: Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model [Phase 1]

View source ↗

Summary

Phase 1 trial assessing local analgesic candidates DCF100, TIB200, and SPR300 versus placebo in a UV-induced pain model; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• DCF100
• SPR300
• TIB200

Snippet

Sponsor: Futura Medical Developments Ltd. | Conditions: Pain | Phase 1 | Status: COMPLETED | Results posted: 2020-09-29